The molecule was advanced into clinical development by the Croatian pharmaceutical company Pliva under the designations PL-10, PLD-116, and PL 14736 for inflammatory bowel disease research
The SNAC-based formulation has strict dosing requirements
Chemically it is () 1, 2, 3, 9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one
Subject to your providers approval, you may be able to safely take your weekly dose up to 2 days (48 hours) before or after your usual day if travel or time zone changes require it
The quality of imputation was assessed through density plots comparing original and imputed distributions for each variable within each brain region, ensuring the preservation of the original data structure ( Supplementary Fig
Weakness and fatigue are common signs of a B12 deficiency, but they can also show up in many other conditions